DK173883A - Substituerede 8-phenylxanthiner - Google Patents

Substituerede 8-phenylxanthiner Download PDF

Info

Publication number
DK173883A
DK173883A DK173883A DK173883A DK173883A DK 173883 A DK173883 A DK 173883A DK 173883 A DK173883 A DK 173883A DK 173883 A DK173883 A DK 173883A DK 173883 A DK173883 A DK 173883A
Authority
DK
Denmark
Prior art keywords
reinforced
steel
diagnostic catheter
micro diagnostic
micro
Prior art date
Application number
DK173883A
Other languages
Danish (da)
English (en)
Other versions
DK173883D0 (da
Inventor
James A Bristol
Edward W Badger
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of DK173883D0 publication Critical patent/DK173883D0/da
Publication of DK173883A publication Critical patent/DK173883A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK173883A 1982-04-21 1983-04-20 Substituerede 8-phenylxanthiner DK173883A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/370,649 US4452788A (en) 1982-04-21 1982-04-21 Substituted 8-phenylxanthines
US37064982 1982-04-21

Publications (2)

Publication Number Publication Date
DK173883D0 DK173883D0 (da) 1983-04-20
DK173883A true DK173883A (da) 1983-10-22

Family

ID=23460567

Family Applications (1)

Application Number Title Priority Date Filing Date
DK173883A DK173883A (da) 1982-04-21 1983-04-20 Substituerede 8-phenylxanthiner

Country Status (7)

Country Link
US (1) US4452788A (pt)
EP (1) EP0092398B1 (pt)
JP (1) JPS58189181A (pt)
AT (1) ATE26115T1 (pt)
DE (1) DE3370482D1 (pt)
DK (1) DK173883A (pt)
GR (1) GR78575B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769377A (en) * 1983-02-18 1988-09-06 The Johns Hopkins University Adenosine receptor antagonists
US4593095A (en) * 1983-02-18 1986-06-03 The Johns Hopkins University Xanthine derivatives
DE3324115A1 (de) * 1983-07-05 1985-01-17 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazole, ihre herstellung und diese verbindungen enthaltende arzneimittel
DE3347290A1 (de) * 1983-12-28 1985-07-11 Dr. Karl Thomae Gmbh, 7950 Biberach Neue 2-phenyl-imidazole, ihre herstellung und diese verbindungen enthaltende arzneimittel
US4612315A (en) * 1984-10-26 1986-09-16 The United States Of America As Represented By The Department Of Health And Human Services Biologically-active 1,3-dipropyl-8-phenylxanthine derivatives
US4696932A (en) * 1984-10-26 1987-09-29 The United States Of America As Represented By The Department Of Health And Human Services Biologically-active xanthine derivatives
GB8510758D0 (en) * 1985-04-27 1985-06-05 Wellcome Found Compounds
JPS62208295A (ja) * 1986-03-07 1987-09-12 Nippon Kayaku Co Ltd ヒポキサンチン塩基を有する新規化合物およびその製造法
US4772607A (en) * 1986-05-20 1988-09-20 Warner-Lambert Company Dialkenyl derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US4755517A (en) * 1986-07-31 1988-07-05 Warner-Lambert Company Derivatives of xanthine, pharmaceutical compositions and methods of use therefor
AT388500B (de) * 1987-10-27 1989-06-26 Wellcome Found Antivirale 8-phenylxanthine
US5298508A (en) * 1988-07-19 1994-03-29 The United States Of America As Represented By The Department Of Health And Human Services Irreversible inhibitors of adenosine receptors
FR2659656B1 (fr) * 1990-03-15 1994-09-09 Sanofi Sa Derives de pyrimidinedione-2,4 et medicaments les contenant.
US5208240A (en) * 1991-03-12 1993-05-04 Merrell Dow Pharmaceuticals Inc. 8-substituted purines as selective adenosine receptor agents
US5484920A (en) * 1992-04-08 1996-01-16 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agent for Parkinson's disease
TW252044B (pt) * 1992-08-10 1995-07-21 Boehringer Ingelheim Kg
JP2613355B2 (ja) * 1992-09-28 1997-05-28 協和醗酵工業株式会社 パーキンソン氏病治療剤
CA2112031A1 (en) * 1992-12-24 1994-06-25 Fumio Suzuki Xanthine derivatives
US5661153A (en) * 1994-07-19 1997-08-26 Japan Energy Corporation 1-arylpyrimidine derivatives and pharmaceutical use thereof
US6545002B1 (en) 1999-06-01 2003-04-08 University Of Virginia Patent Foundation Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors
US20080318983A1 (en) * 2001-11-09 2008-12-25 Rao Kalla A2b adenosine receptor antagonists
US7125993B2 (en) * 2001-11-09 2006-10-24 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
US7317017B2 (en) * 2002-11-08 2008-01-08 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
HU229504B1 (hu) 2001-11-09 2014-01-28 Gilead Sciences A2B-adenozinreceptor-antagonisták
US6977300B2 (en) * 2001-11-09 2005-12-20 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
ES2208063B1 (es) * 2002-04-01 2005-10-01 Almirall Prodesfarma, S.A. Nuevos derivados de la 4-(pirrolopirimidin-6-il)bencenosulfonamida.
WO2006028810A2 (en) * 2004-09-01 2006-03-16 Cv Therapeutics, Inc. Method of wound healing using a2b adenosine receptor antagonists
US20070059740A1 (en) * 2005-08-26 2007-03-15 Linden Joel M Method of targeting a2b adenosine receptor antagonist therapy
US8193200B2 (en) * 2007-01-04 2012-06-05 University Of Virginia Patent Foundation Antagonists of A2B adenosine receptors for treatment of inflammatory bowel disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2840559A (en) * 1954-06-22 1958-06-24 Krantz Jr Nuclearly substituted 8-theophyllines and method of making the same
GB982079A (en) * 1962-05-01 1965-02-03 Dresden Arzneimittel Process for the production of xanthine derivatives
FR5878M (pt) * 1966-07-27 1968-03-18

Also Published As

Publication number Publication date
US4452788A (en) 1984-06-05
EP0092398A1 (en) 1983-10-26
DK173883D0 (da) 1983-04-20
DE3370482D1 (en) 1987-04-30
ATE26115T1 (de) 1987-04-15
JPS58189181A (ja) 1983-11-04
GR78575B (pt) 1984-09-27
EP0092398B1 (en) 1987-03-25

Similar Documents

Publication Publication Date Title
DK173883A (da) Substituerede 8-phenylxanthiner
DE3761307D1 (de) Herstellung von fibraten.
KR840004742A (ko) 아졸릴메틸옥시란의 제조방법
MX158922A (es) Procedimiento para la preparacion de colorantes diazoicos de la serie del 6-metoxibenzatiazol
ES536186A0 (es) Un procedimiento para preparar 5-hidroximetil-2-mercapto-imidazoles sustituidos en posicion 1
NL971020I2 (nl) Azolylmethyloxirane, de bereiding en toepassing ervan als geneesmiddelen en middelen voor het beschermen van planten.
ES555426A0 (es) Un procedimiento para la preparacion de derivados de aciluretano polimerizables.
ATE10838T1 (de) 4-substituierte 2-oxoazetidin-verbindungen, verfahren zu deren herstellung und ihre verwendung zur antibiotika-herstellung.
DK339383D0 (da) Fremgangsmade til fremstilling af allyloxy- og allylthio-2,3,4,5-tetrahydro-1h-3-benzazepiner
DK156197C (da) Fremgangsmaade til fremstilling af et antacidt materiale baseret paa magnesiumaluminiumhydroxid
DK160712C (da) Analogifremgangsmaade til fremstilling af 4-acylamino-1-aza-adamantan-forbindelser
DK467681A (da) Phosphonohydroxyacetonitril og dens salte fremgangsmaade til dens fremstilling og dens anvendelse som mellemprodukt til frestilling af phosphonohydroxyeddikesyre
ES545009A0 (es) Procedimiento de preparacion de nuevas fenil-naftiridinas.
DK195583A (da) Fremgangsmaade til fremstilling af benzoxazin-2-oner
GB1512910A (en) Carbamate-sulphenyl-carbomoyl fluoride compounds
BR7906163A (pt) Processo para a preparacao de n-diazolil-alquil-halogeno-acetanilidas composicoes hercidas e sua aplicacao
DE3272892D1 (en) Substituted pyrimid-2-ones, the salts thereof, processes for their preparation and pharmaceutical compositions containing them
DK467581A (da) Phosphonoformaldehyd og dets salte fremgangsmaade til deres fremstilling og anvendelse af phosphonoformaldehyd som mellemprodukt til fremstilling af phosphonohydroxyeddikesyre
NZ189091A (en) Prostaglandin derivatives
EP0283152A3 (en) Process for the preparation of substituted cyclohexane-1,3,5-triones
EP0094612A3 (en) Novel alkyloxazolylacetic acid derivative, processes for preparation and pharmaceutical compositions containing same
SE8502973L (sv) Framstellning av aminderivat
DK460585A (da) Mellemprodukter til fremstilling af prostatriensyrederivater
EP0194064A3 (en) Azolyl substituted aralkyl compounds
DK85489A (da) Prostaglandinderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
B1 Patent granted (law 1993)